These documents are currently being revised to incorporate the changes made during the 2024 Legislative Session. Please consult the Sections Affected Table for changes made during the 2024 Legislative Session.

48.43.757  <<  48.43.760 >>   48.43.761

Opioid use disorderCoverage without prior authorization.

For health plans issued or renewed on or after January 1, 2020, a health carrier shall provide coverage without prior authorization of at least one federal food and drug administration approved product for the treatment of opioid use disorder in the drug classes opioid agonists, opioid antagonists, and opioid partial agonists.

NOTES:

Declaration2019 c 314: See note following RCW 18.22.810.
Site Contents
Selected content listed in alphabetical order under each group